| Interaction Color Code | Clinical Bottom Line | Clinical Effects | Drug 1 effect | Drug 2 dose | Drug 2 effect | Management | |
|---|---|---|---|---|---|---|---|
| Darunavir Ziprasidone 1022 | Orange: Minimal data to guide interaction | Minimal data to guide interaction: weigh risks and benefits of using this combination | Potential for increased risk of ziprasidone adverse effects |
If coadministering, monitor for adverse effects |
|||
| Elvitegravir Ziprasidone 254 | Orange: Minimal data to guide interaction | Minimal data to guide interaction: weigh risks and benefits of using this combination | Potential for increased risk of ziprasidone adverse effects |
If coadministering start with low dose and titrate accordingly. Monitor for side effects. |
